AGNG


Aging Population ETF

Reasons to Consider AGNG

Long-Term Growth Potential

Humans are living longer than ever, with forecasts suggesting the global population of adults age 60+ could double to more than 2bn by 2050.1

Demographics Drive Consumption

With a ballooning senior population, particularly in western countries, we expect to see waves of innovation catering to their distinct consumer preferences.

Unconstrained Approach

The Aging Population theme is a global trend, affecting a wide range of industries. AGNG invests accordingly, offering exposure to companies regardless of sector or geographic classification.

1WHO, Oct 2021

Key Information As of 02/28/24

Inception Date 05/09/16
Total Expense Ratio 0.50%
Net Assets $57.01 million
NAV $29.39
Fact Sheet View the document

ETF Summary

The Global X Aging Population ETF (AGNG) seeks to invest in companies positioned to serve the world’s growing senior population through exposure to health care, pharmaceuticals, senior living facilities and other sectors that contribute to increasing lifespans and extending quality of life in advanced age.

ETF Objective

The Global X Aging Population ETF (AGNG) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Indxx Aging Population Thematic Index.

Trading Details As of 02/27/24

Ticker AGNG
Bloomberg Index Ticker ILNGRNT
CUSIP 37954Y772
ISIN US37954Y7720
Primary Exchange Nasdaq
Shares Outstanding 1,940,000
Number of Holdings 91
30-Day Median Bid-Ask Spread 0.35%

Distributions As of 02/28/24

30-Day SEC Yield 0.97%
Distribution Frequency Semi-Annually

ETF Prices As of 02/28/24

NAV $29.39 Daily Change -$0.15 -0.51%
Market Price $29.44 Daily Change -$0.13 -0.44%

Performance History

As of recent
(12/31/23)
As of recent
(12/31/23)
Fund NAV Market Price Index
1 Year 9.71% 9.66% 10.08%
3 Years 1.32% 1.35% 1.54%
5 Years 9.17% 9.08% 9.41%
Since Inception 9.39% 9.65% 9.68%
1 Year 6.22% 6.12% 6.62%
3 Years 1.02% 0.82% 1.25%
5 Years 7.05% 6.94% 7.30%
Since Inception 9.20% 9.46% 9.49%
Year-to-Date 9.71% 9.66% 10.08%
1 Month 6.32% 6.45% 6.34%
3 Months 9.66% 9.81% 9.77%
Since Inception 98.65% 102.35% 102.69%
Year-to-Date -0.56% -0.60% -0.50%
1 Month -0.56% -0.60% -0.50%
3 Months 14.16% 13.93% 14.35%
Since Inception 97.54% 101.14% 101.68%

Performance is shown on a total return basis (i.e., with gross income reinvested, where applicable). Cumulative return is the aggregate amount that an investment has gained or lost over time. Annualized return is the average return gained or lost by an investment each year over a given time period.

The performance data quoted represents past performance. Past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than their original cost and current performance may be lower or higher than the performance quoted. High short-term performance, when observed, is unusual and investors should not expect such performance to be repeated.

Top Holdings As of 02/28/24

Net Assets (%) Ticker Name SEDOL Market Price ($) Shares Held Market Value ($)
6.00 LLY ELI LILLY & CO 2516152 757.64 4,443 3,366,194.52
4.68 4519 JP CHUGAI PHARMA CO 6196408 39.50 66,530 2,627,850.08
4.34 NOVOB DC NOVO NORDISK A/S-B BP6KMJ1 121.24 20,099 2,436,888.71
3.86 BSX BOSTON SCIENTIFIC CORP 2113434 66.99 32,357 2,167,595.43
3.66 WELL WELLTOWER INC BYVYHH4 91.86 22,367 2,054,632.62
3.58 SYK STRYKER CORP 2853688 351.80 5,714 2,010,185.20
3.53 REGN REGENERON PHARMACEUTICALS 2730190 987.61 2,008 1,983,120.88
3.50 ALC SW ALCON INC BJT1GR5 84.84 23,148 1,963,785.78
3.28 AMGN AMGEN INC 2023607 277.46 6,626 1,838,449.96
3.25 ABBV ABBVIE INC B92SR70 178.00 10,240 1,822,720.00
3.03 MDT MEDTRONIC PLC BTN1Y11 83.36 20,421 1,702,294.56
3.02 EW EDWARDS LIFESCIENCES CORP 2567116 86.00 19,680 1,692,480.00
2.92 DXCM DEXCOM INC B0796X4 114.22 14,329 1,636,658.38
2.89 JNJ JOHNSON & JOHNSON 2475833 161.55 10,031 1,620,508.05
2.59 AZN ASTRAZENECA PLC-SPONS ADR 2989044 65.35 22,280 1,455,998.00
2.27 BIIB BIOGEN INC 2455965 221.74 5,743 1,273,452.82
2.14 BMY BRISTOL-MYERS SQUIBB CO 2126335 50.92 23,530 1,198,147.60
2.06 RO SW ROCHE HOLDING AG-BR 7108918 280.21 4,122 1,155,031.19
1.98 4543 JP TERUMO CORP 6885074 38.72 28,717 1,112,006.63
1.80 ZBH ZIMMER BIOMET HO 2783815 124.13 8,127 1,008,804.51
1.78 STMN SW STRAUMANN HOLDING AG-REG BQ7ZV06 161.81 6,162 997,066.98
1.52 UCB BB UCB SA 5596991 113.76 7,501 853,328.35
1.44 068270 KS CELLTRION INC B0C5YV1 142.48 5,673 808,271.16
1.37 4503 JP ASTELLAS PHARMA INC 6985383 11.03 69,523 767,074.04
1.30 SOON SW SONOVA HOLDING AG-REG 7156036 309.19 2,363 730,608.83
1.29 BGNE BEIGENE LTD-ADR BYYWPW6 178.48 4,041 721,237.68
1.25 GMAB DC GENMAB A/S 4595739 275.60 2,546 701,681.23
1.17 VTR VENTAS INC 2927925 42.48 15,473 657,293.04
1.02 COH AU COCHLEAR LTD 6211798 224.09 2,551 571,650.76
0.93 INCY INCYTE CORP 2471950 59.98 8,679 520,566.42
0.90 NBIX NEUROCRINE BIOSC 2623911 134.66 3,758 506,052.28
0.81 DEMANT DC DEMANT A/S BZ01RF1 51.04 8,940 456,259.03
0.80 SN/ LN SMITH & NEPHEW PLC 0922320 13.27 33,989 450,935.93
0.80 DVA DAVITA INC 2898087 126.97 3,520 446,934.40
0.79 FME GR FRESENIUS MEDICAL CARE AG 5129074 38.71 11,388 440,847.30
0.78 PODD INSULET CORP B1XGNW4 163.60 2,689 439,920.40
0.73 TFX TELEFLEX INC 2881407 224.45 1,826 409,845.70
0.73 UTHR UNITED THERAPEUTICS CORP 2430412 227.28 1,803 409,785.84
0.70 EXAS EXACT SCIENCES CORP 2719951 56.31 6,937 390,622.47
0.70 3692 HK HANSOH PHARMACEU BJYKB72 1.70 229,043 390,341.05
0.61 BPMC BLUEPRINT MEDICINES CORP BWY52P3 95.45 3,562 339,992.90
0.55 GKOS GLAUKOS CORP BYMWL19 90.04 3,396 305,775.84
0.53 AMP IM AMPLIFON SPA B14NJ71 33.85 8,785 297,344.90
0.51 OHI OMEGA HEALTHCARE 2043274 31.53 9,117 287,459.01
0.50 NHC NATIONAL HEALTHCARE CORP 2139731 97.82 2,871 280,841.22
0.49 EXEL EXELIXIS INC 2576941 21.91 12,613 276,350.83
0.48 ENSG ENSIGN GROUP INC/THE B1YWPP8 124.52 2,170 270,208.40
0.45 AGIO AGIOS PHARMACEUTICALS INC BCBVTX1 33.67 7,431 250,201.77
0.42 CSH-U CN CHARTWELL RETIRE B8S8C94 9.10 26,138 237,942.21
0.41 BKD BROOKDALE SR B0PZN33 5.71 40,215 229,627.65
0.41 ITGR INTEGER HOLDINGS CORP BD06LM7 108.26 2,109 228,320.34
0.38 ACAD ACADIA PHARMACEU 2713317 23.75 9,033 214,488.59
0.38 LIVN LIVANOVA PLC BYMT0J1 55.09 3,863 212,812.67
0.37 HALO HALOZYME THERAPEUTICS INC 2975098 39.69 5,270 209,166.30
0.36 SIA CN SIENNA SENIOR LIVING INC BWTYXH4 9.79 20,546 201,121.06
0.36 SBRA SABRA HEALTH CAR B5NLBP6 14.00 14,226 199,164.00
0.35 AMED AMEDISYS INC 2024332 93.54 2,095 195,966.30
0.35 NHI NATL HEALTH INVESTORS INC 2626125 58.48 3,321 194,212.08
0.34 DCPH DECIPHERA PHARMA BZ1LFB2 16.81 11,221 188,625.01
0.33 8086 JP NIPRO CORP 6641599 8.35 21,952 183,400.32
0.33 6600 HK SCICLONE PHARMAC BMX5ZW2 1.67 109,500 183,255.40
0.32 ALEC ALECTOR INC BJ4LDC4 6.99 25,386 177,448.14
0.32 MMSI MERIT MEDICAL SYSTEMS INC 2580555 80.13 2,210 177,087.30
0.30 GN DC GN STORE NORD A/S 4501093 23.48 7,237 169,892.51
0.28 MNKD MANNKIND CORP BF081J4 3.92 39,719 155,698.48
0.28 AMRN AMARIN CORP PLC -ADR 2301938 1.32 117,452 155,036.64
0.27 LTC LTC PROPERTIES INC 2498788 31.61 4,770 150,779.70
0.26 ATEC ALPHATEC HOLDINGS INC BD60BG7 13.98 10,470 146,370.60
0.26 EKTAB SS ELEKTA AB-B SHS B0M42T2 7.11 20,326 144,490.70
0.25 145720 KS DENTIUM CO LTD BF07GJ6 94.48 1,470 138,892.43
0.25 RYM NZ RYMAN HEALTHCARE LTD 6161525 2.80 49,332 138,164.68
0.25 AED BB AEDIFICA B1G5XP1 57.37 2,404 137,913.91
0.24 DNLI DENALI THERAPEUTICS INC BD2B4V0 20.21 6,684 135,083.64
0.24 OTHER PAYABLE & RECEIVABLES 1.00 132,432 132,432.24
0.24 TBPH THERAVANCE BIOPHARMA INC BMNDK09 9.40 14,047 132,041.80
0.22 9229 JP SUNWELS CO LTD BNTYNB5 19.65 6,374 125,269.61
0.22 PHM SM PHARMA MAR SA BMW2GT8 34.28 3,554 121,832.07
0.21 2186 HK LUYE PHARMA GROUP LTD BNQ4GF3 0.37 317,724 116,899.83
0.18 AGL AGILON HEALTH INC BLR4TK4 6.36 16,079 102,262.44
0.18 1302 HK LIFETECH SCIENTIFIC CORP BV9FKS0 0.26 393,492 100,539.63
0.18 ANGO ANGIODYNAMICS INC B00CR04 5.73 17,528 100,435.44
0.14 EMBC EMBECTA CORP BMXWYR1 14.02 5,780 81,035.60
0.14 1789 HK AK MEDICAL HOLDINGS LTD BFD6SZ0 0.64 119,089 76,678.49
0.13 1858 HK BEIJING CHUNLI-H BVVPXP6 1.24 59,466 73,994.44
0.13 SGHT SIGHT SCIENCES INC BN2T5Q6 4.11 17,757 72,981.27
0.13 SILK SILK ROAD MEDICAL INC BGHVXJ7 17.69 4,007 70,883.83
0.12 853 HK MICROPORT SCIENTIFIC CORP B676TW7 0.98 69,602 68,467.40
0.12 2500 HK VENUS MEDTECH -H BL6V047 0.65 102,940 66,517.26
0.11 NVCR NOVOCURE LTD BYSS4X4 16.02 3,925 62,878.50
0.07 CLARI FP CLARIANE SE B1HKRM0 1.92 20,489 39,358.38
0.03 FGEN FIBROGEN INC BSDRYR8 1.99 8,129 16,136.07
0.00 RADIUS HEALTH INC - CVR 2KFF9T0 0.00 19,104 0.00
0.00 JAPANESE YEN 0.01 -2 -0.01
0.00 EURO 1.08 -114 -123.46
-0.07 CASH 1.00 -41,328 -41,328.18
Holdings are subject to change. "Cash" denotes U.S. dollars.

Exposure As of 01/31/24

Sector Weight (%)
Health Care 93.4
Real Estate 6.6

Source: new windowAltaVista Research, LLC

Industry Weight (%)
Medical Specialties 37.2
Pharmaceuticals: Major 24.9
Biotechnology 18.6
Pharmaceuticals: Other 7.2
Real Estate Investment Trusts 7.1
Medical/Nursing Services 2.7
Hospital/Nursing Management 1.6
Electrical Products 0.4
Telecommunications Equipment 0.3

Source: new windowAltaVista Research, LLC

Country Weight (%)
United States 59.0
Switzerland 8.5
Japan 8.1
Denmark 6.6
Britain 4.0
Ireland 3.6
China 2.8
South Korea 1.7
Belgium 1.6
Australia 0.9
Germany 0.8
Other 2.4

Source: new windowAltaVista Research, LLC

All Sector, Industry and Geographic breakdowns, where provided, are based on equity positions held by the ETF and exclude cash, currencies, and other holdings.

ETF Characteristics As of 02/27/24

Return on Equity 13.80%
Weighted Avg. Market Cap 116,909 M
2023 2024
Price-to-earnings 27.43 23.78
Price-to-book value 3.42 3.14

Source: new windowAltaVista Research, LLC

ETF Risk Stats As of 01/31/24

Versus Beta
S&P 500 0.70
NASDAQ-100 0.49
MSCI EAFE 0.76
MSCI Emg. Mkts 0.52
Standard Deviation 16.00%

Source: new windowAltaVista Research, LLC

ETF Research

Investing involves risk, including the possible loss of principal. The investable universe of companies in which AGNG may invest may be limited. The Fund invests in securities of companies engaged in Healthcare, Pharmaceutical, Biotechnology and Medical Device sectors. These sectors can be affected by government regulations, expiring patents, rapid product obsolescence, and intense industry competition. International investments may involve risk of capital loss from unfavorable fluctuation in currency values, from differences in generally accepted accounting principles or from social, economic or political instability in other nations. AGNG is non-diversified.

Shares of ETFs are bought and sold at market price (not NAV) and are not individually redeemed from the Fund. Brokerage commissions will reduce returns. Beginning October 15, 2020, market price returns are based on the official closing price of an ETF share or, if the official closing price isn’t available, the midpoint between the national best bid and national best offer (“NBBO”) as of the time the ETF calculates current NAV per share. Prior to October 15, 2020, market price returns were based on the midpoint between the Bid and Ask price. NAVs are calculated using prices as of 4:00 PM Eastern Time. The returns shown do not represent the returns you would receive if you traded shares at other times. Indices are unmanaged and do not include the effect of fees, expenses or sales charges. One cannot invest directly in an index.

Carefully consider the Fund’s investment objectives, risks, and charges and expenses before investing. This and other information can be found in the Fund’s summary or full prospectuses. Please read the prospectus carefully before investing.

Global X Management Company LLC serves as an advisor to Global X Funds. The Funds are distributed by SEI Investments Distribution Co. (SIDCO), which is not affiliated with Global X Management Company LLC or Mirae Asset Global Investments. Global X Funds are not sponsored, endorsed, issued, sold or promoted by Indxx, nor does Indxx make any representations regarding the advisability of investing in the Global X Funds. Neither SIDCO, Global X nor Mirae Asset Global Investments are affiliated with Indxx.

AGNG traded under the ticker LNGR from inception until April 1, 2021.